$43.83 +0.05 (%) Abbott Laboratories - NYSE

Nov. 21, 2014 | 03:35 PM

Partner Headlines

  1. Zoetis 2015 Guidance Misses As Buyout Theories Abound

    IBD | Nov. 18, 2014 | 15:15PM EST
  2. Vipshop Leads 4 Top Stocks With Bolting RS Lines

    IBD | Nov. 18, 2014 | 08:02AM EST
  3. Five Ethical Drugmakers Keep Leadership Positions

    IBD | Nov. 17, 2014 | 18:27PM EST
  4. Benzinga's M&A Chatter for Monday November 17, 2014

    Benzinga | Nov. 17, 2014 | 18:11PM EST
  5. Mylan Rises On Q3 Earnings Beat, Affirms Abbott Deal

    IBD | Oct. 31, 2014 | 11:17AM EST
  6. Top 4 NYSE Stocks In The Medical Appliances & Equipment Industry With The Highest Dividend Yield

    Benzinga | Oct. 31, 2014 | 04:59AM EST
  7. Benzinga's M&A Chatter for Wednesday October 29, 2014

    Benzinga | Oct. 29, 2014 | 20:53PM EST
  8. Benzinga's Top Upgrades

    Benzinga | Oct. 29, 2014 | 09:47AM EST
  9. Deutsche Bank Upgrades Abbott Laboratories To Buy

    Benzinga | Oct. 29, 2014 | 08:34AM EST
  10. Deutsche Bank Upgrades Abbott Laboratories

    Benzinga | Oct. 29, 2014 | 08:33AM EST
  11. Amgen Q3 Earnings Beat Estimates; Guidance Mixed

    IBD | Oct. 27, 2014 | 18:56PM EST
  12. Better Biotechs Don't Satisfy

    IBD | Oct. 22, 2014 | 18:53PM EST
  13. Abbott Laboratories Conference Call Highlights

    Benzinga | Oct. 22, 2014 | 16:59PM EST
  14. Biogen, Thermo Reports Disappoint; Abbott Accelerates

    IBD | Oct. 22, 2014 | 11:18AM EST
  15. UPDATE: Abbott Q3 Earnings Top Street View

    Benzinga | Oct. 22, 2014 | 09:21AM EST
  16. Earnings Scheduled For October 22, 2014

    Benzinga | Oct. 22, 2014 | 05:16AM EST
  17. Keep an Eye on These 7 Stocks, October 22nd, 2014

    Benzinga | Oct. 22, 2014 | 04:04AM EST
  18. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga | Oct. 19, 2014 | 10:19AM EST
  19. Making Money With Charles Payne: 10/17/14

    FoxBusiness | Oct. 17, 2014 | 18:00PM EST
  20. AbbVie Rethinking Shire Deal

    IBD | Oct. 15, 2014 | 18:40PM EST
  21. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD | Oct. 15, 2014 | 13:11PM EST
  22. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  23. Screening For Aggressive Buyback Companies

    YCharts | Oct. 8, 2014 | 17:54PM EST
  24. Becton Buyout Of CareFusion Drives Up Both Stocks

    IBD | Oct. 6, 2014 | 11:47AM EST
  25. Jazz Pharmaceuticals Uses New Cash To Buy For Growth

    IBD | Oct. 3, 2014 | 14:39PM EST
  26. Sure Bets: Slow-Changing Industries for Long-Term Investors

    GuruFocus | Oct. 1, 2014 | 18:48PM EST
  27. Market Indicators That Could Spell Trouble for Investors

    GuruFocus | Sep. 29, 2014 | 18:56PM EST
  28. Medical Technology Company Offers Investment Opportunity

    GuruFocus | Sep. 25, 2014 | 16:00PM EST
  29. Inversion Crackdown Leaves Several Deals In Limbo

    Benzinga | Sep. 23, 2014 | 12:41PM EST
  30. Top 4 NYSE Stocks In The Medical Appliances & Equipment Industry With The Highest Revenue

    Benzinga | Sep. 11, 2014 | 04:17AM EST
  31. Abbott: A Brighter Future

    GuruFocus | Aug. 28, 2014 | 14:13PM EST
  32. Buyback Mania Inflates 2Q Earnings Growth

    FoxBusiness | Aug. 14, 2014 | 08:17AM EST
  33. 5 Companies That Have Moved Overseas For Lower Taxes

    Benzinga | Aug. 12, 2014 | 10:06AM EST
  34. 5 Family-Friendly Employers For Working Parents

    Benzinga | Jul. 31, 2014 | 14:10PM EST
  35. 30 Stocks Delisted So Far In 2014

    Benzinga | Jul. 29, 2014 | 16:31PM EST
  36. How Obama Could End Walgreen's Tax-Inversion Hopes

    IBD | Jul. 28, 2014 | 14:41PM EST
  37. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness | Jul. 18, 2014 | 13:23PM EST
  38. Markets Sell-Off After Malaysian Airline Crash In Ukraine

    Benzinga | Jul. 17, 2014 | 16:50PM EST
  39. UPDATE: Morgan Stanley Reiterates On Abbott Laboratories As Growth and Margins Are Set To Continue

    Benzinga | Jul. 17, 2014 | 09:38AM EST
  40. #PreMarket Primer: Thursday, July 17: Russia Hit With New Sanctions

    Benzinga | Jul. 17, 2014 | 07:17AM EST
  41. St. Jude, Abbott beat Street

    IBD | Jul. 16, 2014 | 18:51PM EST
  42. Abbott, St. Jude Top Views, But Stocks Under Pressure

    IBD | Jul. 16, 2014 | 18:10PM EST
  43. Earnings Continue Driving Markets Higher

    Benzinga | Jul. 16, 2014 | 17:23PM EST
  44. Treasury Urges Halt to Tax Inversion M&A 'Abuse'

    IBD | Jul. 16, 2014 | 15:28PM EST
  45. Abbott Laboratories Conference Call Highlights

    Benzinga | Jul. 16, 2014 | 12:11PM EST
  46. St. Jude, Abbott Labs Earnings Beat Q2 Estimates

    IBD | Jul. 16, 2014 | 10:54AM EST
  47. UPDATE: Abbott Posts Upbeat Q2 results, Lifts Forecast

    Benzinga | Jul. 16, 2014 | 08:39AM EST
  48. #PreMarket Primer: Wednesday, July 16: Yellen Hints At Sooner Than Expected Rate Hike

    Benzinga | Jul. 16, 2014 | 07:19AM EST
  49. Earnings Scheduled For July 16, 2014

    Benzinga | Jul. 16, 2014 | 05:26AM EST
  50. Stocks To Watch For July 16, 2014

    Benzinga | Jul. 16, 2014 | 04:16AM EST
Trading Center